News
FDA Fully Approves Moderna's COVID Vaccine for Some Young Kids
The move makes Moderna’s vaccine, called Spikevax, the first COVID shot for kids in the U.S. to be fully approved, rather than used under emergency authorization, STAT News reported. The vaccine can now be given to children ages 6 months through 11 years, but only if they have at least one health issue that increases their COVID risk.
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement ...
Moderna’s coronavirus vaccine is similar to the Pfizer-BioNTech vaccine that was authorized and shipped out to Americans earlier this week. But there are a few key differences.
Moderna's vaccine candidate was found to be 94.1% effective in preventing COVID-19 in clinical trials, and it doesn't trigger severe side effects in most people.
Moderna, the maker of one of three COVID-19 vaccines currently authorized for use in the U.S., announced Tuesday it will start testing its vaccine on children as young as 6 months old.. The ...
In the Moderna trial, 90 of the first 95 participants to develop COVID-19 had received the placebo and only five the active vaccine, so it was 94.5% effective. Results from another 56 ...
Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is ...
Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback